Obesity drugmaker Novo Nordisk reports fourth-quarter earnings

May 16, 2025

FILE PHOTO: Chief Executive Lars Fruergaard Joergensen presents earnings results for drugmaker Novo Nordisk in Bagsvaerd, Denmark February 5, 2025. Ritzau Scanpix/Mads Claus Rasmussen via REUTERS/File photo